Close Menu

CPT codes

In a letter to CMS, AMP made a case for crosswalking existing CPT codes for BRCA1/2 testing to codes that more accurately reflect the work required to analyze these genes.

The firm has struggled in the past to convince payors of its test's clinical utility but remains dedicated to convincing the field that Epi proColon can help patients by closing CRC screening gaps.

Since last year the AMA has issued 23 PLA codes for firms that want to better track use of their tests, but the effect of the codes on improving reimbursement remains to be seen.

The panel's decisions could change the codes diagnostic companies use to bill payors for these tests, which could affect revenue.

The new code is used for tests conducted by next-generation sequencing that include BRCA1, BRCA2, and 12 other genes even if they are part of multi-gene panels.

The coding requirements will be a particularly complicated aspect of implementing the new law which aims to move diagnostic pricing to a market-based system.

Medicare Administrative Contractors didn't price codes describing whole-genome or exome sequencing, or cancer panels gauging 51 or more genes.

NEW YORK (GenomeWeb) – The Centers for Medicare & Medicaid Services has released its preliminary clinical laboratory fee schedule (CLFS) deter

NEW YORK (GenomeWeb) – Medicare contractor Palmetto GBA has issued draft local coverage determinations stipulating reimbursement criteria for three multi-marker molecular diagnostics: Assurex Health's pharmacogenetic test for refractory depression, MDxHealth's ConfirmMDx epigenetic prostate cance

Originally published April 1.
The threat of across-the-board payment cuts for lab tests has spurred the seemingly impossible: consensus within the diagnostics industry around a common purpose.

Pages

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.